Stop myopia progression.
Data-driven. Clinically precise.
ClearSight consolidates axial length, refraction data, and treatment protocols into a single platform — giving optometrists and ophthalmologists the analytical edge to slow progression and improve long-term outcomes.
Trusted by leading practices across 28 countries
Axial Length
Myopia Index
Treatment Adherence · Week 12
Total Eye Growth So Far
Platform capabilities
From first consultation to long-term monitoring, ClearSight provides the infrastructure to deliver evidence-based myopia care at scale.
Track biometric progression over time with percentile benchmarks derived from over 2 million anonymised data points. Identify fast progressors before they exceed clinical thresholds.
Apply evidence-based protocols — orthokeratology, DIMS, atropine titration, MiSight — and receive AI-generated dosing recommendations calibrated to individual progression velocity.
Automated reminders, parent-facing progress reports, and a native patient portal ensure treatment plans are followed through — dramatically improving real-world efficacy rates.
Clinics onboarded across 28 countries
Measurement accuracy vs. reference biometers
Better progression outcomes vs. no management
Average consultation time saved per patient visit
What clinicians say
"ClearSight has fundamentally changed how we approach paediatric myopia. The axial length trending and automated protocol suggestions have cut our review time in half — and our outcomes data has never been stronger."
Dr. Sarah Lim, OD FAAO
Clinical Director · Pacific Eye Institute, Singapore
"The FHIR integration connected ClearSight to our existing EMR in a single afternoon. Three months in, our parent satisfaction scores are up 31%. The platform simply does what it promises — with exceptional precision."
Dr. Marco Rossi, MD
Paediatric Ophthalmologist · Clinica Oculistica Milano
Ready to start?
Join 2,400+ practices already using ClearSight. No setup fees. No lock-in. Full data portability on day one.
ClearSight consolidates axial length, refraction data, and treatment protocols into a single platform, giving optometrists and ophthalmologists the analytical edge to slow progression and improve long-term outcomes.
From first consultation to long-term monitoring, ClearSight provides the infrastructure to deliver evidence-based myopia care at scale.
Track biometric progression over time with percentile benchmarks derived from anonymised datasets, and identify fast progressors before they exceed clinical thresholds.
Apply evidence-based protocols such as orthokeratology, DIMS, atropine titration, and MiSight, with recommendations calibrated to progression velocity.
Automated reminders, parent-facing progress reports, and a native patient portal help treatment plans translate into better real-world compliance.
Clinics onboarded across 28 countries.
+340 this quarterMeasurement accuracy vs. reference biometers.
ISO 13485 certifiedBetter progression outcomes vs. no management.
Peer-reviewed, 2023Average consultation time saved per patient visit.
22hrs/month per practice“ClearSight has fundamentally changed how we approach paediatric myopia. Axial length trending and protocol suggestions have cut review time in half, while our outcomes data has become stronger and easier to communicate.”
“The integration into our workflow was remarkably fast. Three months in, parent satisfaction is up, documentation is cleaner, and the platform has delivered the level of precision it promised.”
Join practices already using ClearSight. No setup fees, no lock-in, and full data portability from day one.